RiverBabe's Baby Biotechs

[riverbabe]

Beware ELN

Check ELN. New 52 week high.

Not that Adam is always right, but he's pretty good...

http://www.thestreet.com/story/11460421/1/elans-alzheimers-fueled-run-means-investors-are-forgetting-the-past.html

[IIC]

Check ELN. New 52 week high.

ELN was on http://MrBreakout.com on Thursday

[stocks54]

Eln

Check ELN. New 52 week high.

[billyjoe]

HALO , new high. HTI- 501 Cellulite treatment Phase 2 trials.


----------billy

[riverbabe]

Apparently nobody knows: (start at bottom)

davidmarisDavid Maris
@
adamfeuerstein $CRIS +10% in the past 5 days before announcement vs. a flat market - pops on the announcement, then sells off #interesting

adamfeuersteinAdam Feuerstein

Roche struck early licensing deals w. $CRIS and $IMGN when both were young and kinda desperate -- only pay out small royalty streams.

20 hours ago FavoriteRetweetReply

BioRunUpBioRunUp

Why $CRIS is selling off? $10M milestone and "a low-to-mid single digit royalty." $377M Mkt Cap on this stock...


GekkowireGekkoWire
To be precise $CRIS gets "a low-to-mid single digit royalty." How much is 3% of even the biggest blockbuster one could think of? NOT MUCH

21 hours ago FavoriteRetweetReply

GekkowireGekkoWire

$CRIS only gets single digit royalties.

21 hours ago

SuperrflySuperrfly

$CRIS everybody and their dog was in, hence the drop.

21 hours ago FavoriteRetweetReply

BioRunUpBioRunUp

$CRIS tanking.... $4.71. Dont worry everyone, Im sure @SheffStation sold at the high.

21 hours ago


sharkbiotechDan Rosenblum

$CRIS panic sell the news rearing its ugly head

21 hours ago

[tiedyed1]

Thinking of the old adage it's better to remain silent and be thought stupid than to speak and remove all doubt I'll ask why is CRIS down?

I am very confused about the movements on CRIS today. Before I knew of any news I was thinking market makers were playing games and the huge volume was scare tactics.

With that type of news, 'sell on the news' does not make sense to me either!

[Louetta]

BioRunUpBioRunUp

$CRIS FDA Approval just hit the wires... slow non-twitter based market now reacting.

Thinking of the old adage it's better to remain silent and be thought stupid than to speak and remove all doubt I'll ask why is CRIS down?

[tiedyed1]

BioRunUpBioRunUp

$CRIS FDA Approval just hit the wires... slow non-twitter based market now reacting.

I sold last week and considering whether this is a new entry point...

[riverbabe]

Cris 11:32AM

BioRunUpBioRunUp

$CRIS FDA Approval just hit the wires... slow non-twitter based market now reacting.

[riverbabe]

Cris

Tie, Early approval. Hope you sold high.


$CRIS tanking.... $4.71. Dont worry everyone, Im sure @SheffStation sold at the high.

4 minutes ago FavoriteRetweetReply


BioRunUpBioRunUp

$CRIS only up 6% on FDA Approval... so far...

11 minutes ago

adamfeuersteinAdam Feuerstein

$CRIS -- the FDA announcement re vismodegib approval. Early!! --> http://1.usa.gov/wwcv1k

14 minutes ago FavoriteRetweetReply

adamfeuersteinAdam Feuerstein

Roche and $CRIS -- FDA approves vismodegib for basal cell carcinoma, reports StreetAccount

[riverbabe]

Hi River;

It has been some time since I asked you about CRIS and it has been very good to me this past 6 months. It has a nice pop >5 today but I do not see any news and wondering if you see anything that would spark this latest move.

Your opinion is truly appreciated; -Adam
tiedyed1

I found this from today: http://investors.curis.com/releasede...leaseID=642322
and this:

http://www.thestreet.com/story/11350254/2/27-hot-drugs-facing-fda-approval-in-2012.html

Roche(RHHBY) and Curis(CRIS_)
Drug/indication: Vismodegib for advanced basal cell carcinoma.
Approval decision date: March 8, 2012.

GL with it!

[tiedyed1]

CRIS news?

This is the latest on the live blog (see below) on CRIS! Sounds goods!
adam feuerstein: last presentation on GDC-0449 from Curis. (hey! it's a small cap bio, so pay attention!!!)
Saturday June 5, 2010 10:50 adam feuerstein

10:51 adam feuerstein: first report on activity of GDC-0449 in patients with medulloblastoma (the most common brain tumor in children)
Saturday June 5, 2010 10:51 adam feuerstein

10:51 adam feuerstein: about 400 kids in the U.S. are diagnosed iwth medulloblastoma each year
Saturday June 5, 2010 10:51 adam feuerstein

10:53 adam feuerstein: Small, phase I study show encouraging activity. 12/13 children with recurrent or drug-resistant medulloblastoma tolerated drug well without significant side effects. one patients remained on drug for more than a year without disease progression - very atypical in this disease.
Saturday June 5, 2010 10:53 adam feuerstein

10:55 adam feuerstein: Will be interesting to see if Curis sees some action monday based on these data. Recall, Curis is partnered with Roche/Genentech. GDC-0449 is also being studied in other tumor types.

Hi River;

It has been some time since I asked you about CRIS and it has been very good to me this past 6 months. It has a nice pop >5 today but I do not see any news and wondering if you see anything that would spark this latest move.

Your opinion is truly appreciated; -Adam
tiedyed1

[riverbabe]

River,
This is off the Biotech subject but I'd like your current take on GMCR and SBUX. Mrs. Billy had a bunch of the girls over last night. I disappeared upstairs to watch the football game. after everyone cleared out I asked Beth if they drank wine, pop, or whatever. Turns out they sat around drinking coffee from the Keurig machine our younger son gave her for Christmas. I suspect some Bailey's Irish Cream was added. We've got a big tub of various K cups and they were a big hit. Is coffee still the next big thing?


--------------billy

Keurig is sure gaining popularity as a great way to make coffee and give a variety of taste choices. But is it the "next big thing?"

The GMCR daily chart shows an attempt to break out of a volatility squeeze, but without conviction at this point; the weekly showing an attempt to break through the 50 sdma. They report Feb. 1st. If it does break out with high volume, it may have a good run (market permitting). Personally I am cautious. But a short term trade on an upward move on big volume might be a possibility.

SBUX getting tepid reviews on its new "blonde" flavors. SBUX daily showing some consolidation after a nice upward trend. The weekly showing a couple of dojis and indecision. Again I'm cautious. In general, I prefer GMCR to SBUX because there is more variety and probably more room to grow. My gurus are saying we may get a market up condition for a few weeks, but with negative divergences. And so it goes...

But I love my Keurig coffee maker, that I've enjoyed for four years now without regret! My favorites are Nantucket Blend, Donut Shop, Caribou and anything Kona roast. Got a Raspberry flavored boxful for Christmas that, even though I'm not big on flavored coffee, am looking forward to trying.

[billyjoe]

River,
This is off the Biotech subject but I'd like your current take on GMCR and SBUX. Mrs. Billy had a bunch of the girls over last night. I disappeared upstairs to watch the football game. after everyone cleared out I asked Beth if they drank wine, pop, or whatever. Turns out they sat around drinking coffee from the Keurig machine our younger son gave her for Christmas. I suspect some Bailey's Irish Cream was added. We've got a big tub of various K cups and they were a big hit. Is coffee still the next big thing?


--------------billy

[billyjoe]

River,
It looks like KMR's dividend is below 3.5%. Please make another pick.

-------------billy